Exam 7: Diabetes Flashcards
Thiazolidinediones uses
Type 2 diabetes
Pioglitazone is only one commonly prescribed
Taken daily in combo with other drugs for diabetes
Effects are mediated by gene expression, so it may take 1-3 months to see benefits
Name 1 alpha-glucosidase inhibitor
Acarbose
Acarbose
Alpha-glucosidase inhibitor
Used for type 2 DM, pre diabetes
Slowly titration up to desired dose
Inhibits enzymes that break down complex carbs
Delays and spreads out absorption of glucose after meals
Minimally absorbed
If a patient on Acarbose gets hypoglycemic, they need to get glucose or dextrose, not sucrose which requires alpha-glucosidase to be broken down
Acarbose adverse effects
GI disturbances
Flatulence, diarrhea, abdominal pain
Side effects get less prominent over time due to up regulation of alpha-glucosidases in the distal small intestines
Acarbose contraindications
IBD
Renal impairment
Other GI problems
Which bile acid sequesterant can be used in treatment of DM?
Colesevelam
Pramlintide
Amylin analog, acts on receptor in hindbrain
Suppresses Glucagon release, delays gastric emptying….
Can cause nausea, weight loss, hypoglycemia.
Adjunct to insulin therapy, must be injected separately
Lowers amount of insulin need, mealtime insulin doses should be reduced by about 50%
Pramlintide contraindications
Gastroparesis or any other GI motility disorder
GLP-1 agonist
Exenatide
Exenatide
Synthetic exenidin 4, an incretin
Glucagon like peptide 1 receptor agonist
Therapy for type DM
Causes increased insulin synthesis and secretion in a glucose dependent manner (as opposed to sulfonureas). Less likely to cause hypoglycemia
Also causes delayed gastric emptying and decreased appetite
Also suppresses post prandial glucagon release
Rapidly absorbed after injection
GI disturbances are a common side effect
Liraglutide
GLP1 agonist
Like Exenatide, but is more slowly absorbed. It also binds to albumin, slowing its metabolism
Black box warning, not for use in patients with family history of medullary cancer or multiple endocrine neoplasia type 2
GLP1 agonist adverse effects
GI disturbances Weight loss Hypoglycemia maybe Pancreatitis Can alter pharmacokinetics of drugs that require Rapid GI absorption
GLP1 contraindication
Pancreatitis
DPP-4 inhibitors
Sitagliptin
Other gliptins
Sitagliptin
DPP-4 inhibitor
Increases levels of circulating incretins
Can be taken orally
Result in increased insulin, decreased glucagon release after meals